Literature DB >> 21499728

Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.

Leonard Da Silva1, Daniel James, Peter T Simpson, Daniel Walker, Ana Cristina Vargas, Janani Jayanthan, Sunil R Lakhani, Anne Marie McNicol.   

Abstract

We report a follicular carcinoma of thyroid that showed a range of histologic appearances, with microfollicular, macrofollicular/pseudopapillary, oncocytic, and poorly differentiated areas. We used comparative genomic hybridization to detect the major DNA copy number changes in each component, in order to study the inter-relationships among them. All showed gains in 11q and 17q, suggesting that these were early events in the development of the tumor, and these were the only changes in the follicular component. The other components each showed additional gains and losses, some unique to one component. The oncocytic component showed most changes, including loss on 16q in the region of the E-cadherin gene. This was associated with reduced intensity of immunostaining for E-cadherin specifically in that component. No mutations in the E-cadherin gene were detected in this component. The demonstration that some DNA copy number changes are consistent across each component suggests that they are all clonally related. The additional chromosomal and immunohistochemical heterogeneity across the macrofollicular/pseudopapillary, oncocytic, and poorly differentiated components would be consistent with the emergence of subclones, possibly as part of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499728     DOI: 10.1007/s12022-011-9154-y

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  16 in total

1.  Immunohistochemical diagnosis of papillary thyroid carcinoma.

Authors:  C C Cheung; S Ezzat; J L Freeman; I B Rosen; S L Asa
Journal:  Mod Pathol       Date:  2001-04       Impact factor: 7.842

2.  Follicular thyroid carcinoma: chromosome analysis of 19 cases.

Authors:  L Roque; A Clode; G Belge; A Pinto; S Bartnitzke; J R Santos; B Thode; J Bullerdiek; S Castedo; J Soares
Journal:  Genes Chromosomes Cancer       Date:  1998-03       Impact factor: 5.006

3.  A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness.

Authors:  Jennifer L Hunt; Virginia A Livolsi; Zubair W Baloch; Patricia A Swalsky; Anke Bakker; E Sasatomi; Sydney Finkelstein; E Leon Barnes
Journal:  Hum Pathol       Date:  2003-04       Impact factor: 3.466

4.  Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas.

Authors:  Yoon-La Choi; Mi Kyung Kim; Jin-Won Suh; Joungho Han; Jung Han Kim; Jung Hyun Yang; Seok Jin Nam
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

5.  E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.

Authors:  A S Rocha; P Soares; E Fonseca; J Cameselle-Teijeiro; M C Oliveira; M Sobrinho-Simões
Journal:  Histopathology       Date:  2003-06       Impact factor: 5.087

6.  Genetic Changes in Chromosomes 1p and 17p in Thyroid Cancer Progression.

Authors:  Celina G. Kleer; Bonita R. Bryant; Thomas J. Giordano; Mark Sobel; Maria J. Merino
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

7.  Aberrant expression of E-cadherin in lobular carcinomas of the breast.

Authors:  Leonard Da Silva; Suzanne Parry; Lynne Reid; Patricia Keith; Nic Waddell; Myriam Kossai; Catherine Clarke; Sunil R Lakhani; Peter T Simpson
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

8.  Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.

Authors:  Nobuyuki Wada; Quan-Yang Duh; Daishu Miura; Laurent Brunaud; Mariwil G Wong; Orlo H Clark
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

9.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

10.  Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

Authors:  S Hemmer; V M Wasenius; S Knuutila; H Joensuu; K Franssila
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more
  2 in total

1.  Cancer heterogeneity: origins and implications for genetic association studies.

Authors:  Davnah Urbach; Mathieu Lupien; Margaret R Karagas; Jason H Moore
Journal:  Trends Genet       Date:  2012-07-31       Impact factor: 11.639

2.  Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.

Authors:  Bartosz Wojtas; Aleksandra Pfeifer; Malgorzata Oczko-Wojciechowska; Jolanta Krajewska; Agnieszka Czarniecka; Aleksandra Kukulska; Markus Eszlinger; Thomas Musholt; Tomasz Stokowy; Michal Swierniak; Ewa Stobiecka; Ewa Chmielik; Dagmara Rusinek; Tomasz Tyszkiewicz; Monika Halczok; Steffen Hauptmann; Dariusz Lange; Michal Jarzab; Ralf Paschke; Barbara Jarzab
Journal:  Int J Mol Sci       Date:  2017-06-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.